跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gecibixil - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gecibixil
Approved
STANDARD
Gecibixil
Getwell Pharmaceuticals
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
56737ff1ba041cdd
Company
Getwell Pharmaceuticals
Type
Standard
Approval Details
Approval Id
56737ff1ba041cdd
Drug Approval Philippines Name
Gecibixil
Product Name
Gecibixil
Registration Number
DRP-6330-02
Brand Name
Gecibixil
Generic Name
Gemcitabine (as hydrochloride)
Dosage Form
Lyophilized Powder For Injection (I.V.)
Dosage Strength
1 g
Manufacturer
Getwell Pharmaceuticals
Importer
Ambica International Corporation
Distributor
Globo Asiatico Enterprises, Inc.
Issuance Date
27 September 2024
Expiry Date
01 September 2030
Pharmacologic Category
Antineoplastic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
56737ff1ba041cdd
Type
Standard
Back to Philippines FDA Approvals